Question
How is Cochlear making sure the newest products, like the Nucleus® 7 Sound Processor, are accessible to the earliest cochlear implantees?
Answer
Cochlear’s first implant recipients have been part of the Cochlear Family since 1982. As pioneers leading the way for every recipient who came after them, we are excited to announce the launch of Nucleus 7 compatibility with the first generation Nucleus 22 implant.
This means that Nucleus 22 implant recipients can upgrade to Cochlear’s latest behind-the-ear sound processor, and for the first time, benefit from the smallest and lightest behind-the-ear sound processor with direct smartphone connectivity and streaming capabilities.1
N22 recipients were implanted long before main stream mobile devices. Now, using their smartphones and Nucleus SmartApp, these recipients can:
- Answer a call
- Stream audio unilaterally, bilaterally or bimodally
- Monitor and control their sound processor
- Improve hearing in noise with Forward Focus*
- Enjoy the peace of mind that comes from being able to locate a misplaced sound processor
Last but not least, there are no additional attachments or additional intermediary devices necessary. We are committed to a lifetime of support for our recipients and are excited to offer Nucleus 7 for N22 recipients.
For more information about Cochlear’s latest innovations please visit Cochlear ProNews.
References:
- Cochlear Limited. D1190805. CP1000 Processor Size Comparison. 2017, Mar; Data on file.
© Cochlear Limited 2020. All rights reserved. Hear now. And always and other trademarks and registered trademarks are the property of Cochlear Limited or Cochlear Bone Anchored Solutions AB. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
This content is meant for professional use. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information. Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
The Cochlear Nucleus 7 Sound Processor is compatible with iPhone®, iPad® and iPod® touch. Apple, the Apple logo, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone®, iPad® Pro, iPad® Air, iPad® mini, iPad® and iPod® touch are trademarks of Apple Inc., registered in the U.S. and other countries. The Cochlear Nucleus Smart App is available on App Store and Google Play. For complete smartphone compatibility information, please visit www.cochlear.com/compatibility.
App Store is a service mark of Apple Inc., registered in the U.S. and other countries.
Android™ and Google Play are registered trademarks of Google Inc.
*ForwardFocus can only be enabled by a hearing implant specialist. It should only be activated for users 12 years and older who are able to reliably provide feedback on sound quality and understand how to use the feature when moving to different or changing environments. It may be possible to have decreased speech understanding when using ForwardFocus in a quiet environment.
